Correction to: Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study

Antzeko izenburuak

• Elderly patients with atrial fibrillation in routine clinical practice—peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study
  nork: Unverdorben, M., et al.
  Argitaratua: (2020)
• Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT‐AF/VTE study
  nork: Colonna, Paolo, et al.
  Argitaratua: (2020)
• Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT‐AF/VTE)—Trial design
  nork: Colonna, Paolo, et al.
  Argitaratua: (2018)
• Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)
  nork: De Caterina, Raffaele, et al.
  Argitaratua: (2019)
• Anticoagulation During AF Ablation: The Balance between Thromboembolism and Bleeding
  nork: Mears, Jennifer A, et al.
  Argitaratua: (2009)